eHealthMe - Personalized health information & community eHealthMe - Personalized health information & community

Personalized health information & community

All drugs: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
All conditions: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Check symptoms   -   Check drugs   -   Compare drugs   -   Join a support group   -   More tools

Would you have Tendonitis when you have Multiple sclerosis?

Summary: Tendonitis is found among people with Multiple sclerosis, especially people who are female, 50-59 old, also have Osteoporosis, and take medication Tysabri.

We study 169 people who have Tendonitis and Multiple sclerosis from FDA and social media. Find out below who they are, other conditions they have and drugs they take.

You are not alone: join a support group for people who have Multiple sclerosis and Tendonitis >>>


Multiple sclerosis

Multiple sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath) can be treated by Copaxone, Tysabri, Avonex, Rebif, Baclofen, Betaseron. (latest reports from 224,277 Multiple Sclerosis patients)


Tendonitis (a condition that causes pain and swelling of tendons) has been reported by people with osteoporosis, sinusitis, high blood cholesterol, osteopenia, urinary tract infection. (latest reports from 9,551 Tendonitis patients)

On Apr, 26, 2015: 169 people who have multiple sclerosis and Tendonitis are studied.

Trend of Tendonitis in multiple sclerosis reports

Gender of people who have multiple sclerosis and experienced Tendonitis * :


Age of people who have multiple sclerosis and experienced Tendonitis * :


Severity of the symptom * :

leastmoderateseveremost severe

Top co-existing conditions for these people * :

  1. Osteoporosis (6 people, 3.55%)
  2. Muscle spasms (4 people, 2.37%)
  3. Bipolar disorder (3 people, 1.78%)
  4. Pituitary tumour (3 people, 1.78%)
  5. Intervertebral disc protrusion (2 people, 1.18%)
  6. Depression (2 people, 1.18%)
  7. Anxiety (1 people, 0.59%)
  8. Dyspnoea (1 people, 0.59%)
  9. Relapsing-remitting multiple sclerosis (1 people, 0.59%)
  10. Fibromyalgia (1 people, 0.59%)

Most common drugs used by these people * :

  1. Tysabri (94 people, 55.62%)
  2. Avonex (84 people, 49.70%)
  3. Rebif (14 people, 8.28%)
  4. Xanax (8 people, 4.73%)
  5. Betaseron (7 people, 4.14%)
  6. Baclofen (6 people, 3.55%)
  7. Provigil (6 people, 3.55%)
  8. Celebrex (5 people, 2.96%)
  9. Demadex (4 people, 2.37%)
  10. Acyclovir sodium (4 people, 2.37%)

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Get connected: join our support group of multiple sclerosis and tendonitis on

Do you have Multiple Sclerosis and Tendonitis?




You are not alone! Join a support group on :
- support group for people who have Tendonitis and Multiple sclerosis
- support group for people who have Multiple sclerosis
- support group for people who have Tendonitis

Could your drug cause:

Other conditions that could cause:

Recent related drug studies (Check your drugs):

Recent Multiple Sclerosis related drug comparison:

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.


About - Terms of service - Privacy policy - Press - Testimonials - Contact us -

© 2015 All rights reserved. Use of this site constitutes acceptance of's terms of service and privacy policy.